🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseHas anyone dealt with had a fibroscan and do not understand my results - help? Page 6

Has anyone dealt with had a fibroscan and do not understand my results - help?

pat_auckland Fri, Apr 5, 2024 at 7:32 AM 42 replies 2,471 viewsPage 6 of 9
laura_annarbor
Member
189
890
Dec 2024
Ann Arbor, MI
Apr 8, 2024 at 1:23 PM#26
jason_paloalto said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Agreed, and one caution: a single measurement is not a measurement. Anything that moves day to day needs a trend before it means anything at all.

Last edited: Apr 8, 2024 at 3:23 PM
11 9labquiet_amy, emily_PDX, Dr.SleepRoch and 8 others
Reply Quote Save Share Report
mike.trainer_LA
Senior Member
1,567
7,234
Apr 2024
Los Angeles, CA
Apr 8, 2024 at 9:44 PM#27
jason_paloalto said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Bookmarking. The distinction being drawn above is the one nobody else makes.

12 10newstart_MO, mia_MS2, LeilaHI and 9 others
Reply Quote Save Share Report
NurseLeah_Nash
Member
278
1,234
Sep 2024
Nashville, TN
Apr 9, 2024 at 6:04 AM#28

Adding the clinical framing, because it changes how the question reads. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

Happy to go further on any of that.

Last edited: Apr 9, 2024 at 7:04 AM
13 11PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 10 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
RunnerRach
Member
467
2,123
Aug 2024
Boston, MA
Apr 9, 2024 at 2:24 PM#29
NurseLeah_Nash said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Same experience, arrived at from the opposite direction.

14 12jennifer_SEA, tyler_CSCS, VanRx_Mike and 11 others
Reply Quote Save Share Report
pat_auckland
Member
345
1,567
Jun 2024
Auckland, NZ
Apr 9, 2024 at 10:44 PM#30

Reporting back.

Reporting back for the archive rather than for the thread: I did the narrow version of what was suggested, gave it the full interval, and it settled. Posting it because threads without a follow-up are half a thread.

Last edited: Apr 10, 2024 at 2:44 AM
36 9dan_philly, MeganSA_TX, LarryQC_SD and 33 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register